TrialThe lancet. Gastroenterology & hepatology2021

Safety and activity of trifluridine/tipiracil and ramucirumab in previously treated advanced gastric cancer: an open-label, single-arm, phase 2 trial.

Akihito Kawazoe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.